Figure 4
Subgroup analysis: risk of adverse outcomes of adherent NOAC use (PDC ≥80%) compared with non-adherent use (PDC <80%) in each subgroup. CI, confidence interval; HR, hazard ratio; ICH, intracranial haemorrhage; NOAC, non-vitamin K antagonist oral anticoagulant; PDC, proportion of days covered.

Subgroup analysis: risk of adverse outcomes of adherent NOAC use (PDC ≥80%) compared with non-adherent use (PDC <80%) in each subgroup. CI, confidence interval; HR, hazard ratio; ICH, intracranial haemorrhage; NOAC, non-vitamin K antagonist oral anticoagulant; PDC, proportion of days covered.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close